43rd Symposium on Hormones and Cell Regulation

The brain–gut–microbiome network in metabolic regulation and dysregulation

Preliminary Programme

Wednesday 10th October

15:00 – 16.00  Bus arrives and cold lunch

16:00 – 16:10  Welcome

16:10 – 18:10  Cross-talk between the gut and the brain in metabolic regulation (Chair: Stephane Schurmans)

16:10 – 16:50  Jarrad M.Scarlett, University of Washington. Seattle, USA
Role of the brain in the pathogenesis of obesity, insulin resistance and type 2 diabetes.

16:50 – 17:30  Shiho Fujisaka, University of Toyama, Japan
Interaction between the gut microbiota and metabolites in insulin resistance and metabolic syndrome.

17:30 – 18:10  Amandine Everard, UCL, Brussels, Belgium
Cross-talk between the gut microbiota and the brain during metabolic disorders.

18:10 – 18:50  Vassilis Pachnis, Francis Crick Institute, London, UK
Control of the gastrointestinal tract by the enteric neuronal system.

19:00 – 20:30  Dinner

20:30 – 21:30  The first Jacques E. Dumont keynote lecture (Chair: Nathalie Delzenne)
Jens Juul Holst, University of Copenhagen, Denmark
The endocrine function of the gut.

21:30 Poster session

Thursday 11th October

8:30 – 13:00   The gut microbiota: a complex ecosystem and its interaction with host cells (Chair: Stefan Offermanns)

8:30 – 9:10  Colin Hill, University College Cork, Ireland
Overview of gut bacteriophages and their role in shaping the microbiome.

9:10 – 9:50  Oluf B. Pedersen, University of Copenhagen, Denmark
Human gut microbes impact host serum metabolome and insulin sensitivity.

9:50 – 10:30  Eran Elinav, Weizmann Institute, Jerusalem, Israel
Environmental, nutritional and endogenous modulation of the microbiota.

10:30 – 11:00  Coffee break

11:00 – 11:40  Siegfried Ussar, Helmholtz Diabetes Center, München, Germany
Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome.

11:40 – 12:20  Peter Holzer, University of Graz, Austria
Gut – brain – microbiome interactions in obesity and depression.

12:20 – 13:00  Two short talks from abstracts.

13:00 – 14:30   Lunch

14:30 – 16:30   Walk around Mt Ste Odile

16:30 – 19:10   New mediators/targets in gut function (Chair: Veit Flockerzi)

16:30 – 17:10  Bart Staels, Institut Pasteur, Lille, France
Bile acids as metabolic regulators of endocrine function and energy metabolism.

17:10 – 17:50  Ellen Blaak, Maastricht University, The Netherlands
Short chain fatty acids as mediators of host energy metabolism.

17:50 – 18:30  Gilles Mithieux, INSERM, Lyon, France
Regulation of intestinal gluconeogenesis: which consequences for neuroendocrine function and energy metabolism?

18:30 – 20:00  Dinner

20:00 – 21:00  Keynote lecture (Chair: Pierre De Meyts)   

Karine Clément, Pitié-Salpêtrière, Paris, France
Organ cross-talk in the pathophysiology of obesity

21:00  Poster session

Friday 12th October

8:30 - 12:30  The gut microbiome in metabolic regulation and dysregulation across lifespan (Chair: Adriana Maggi)

8:30 – 9:10  Herbert Tilg, Medical University, Innsbrück, Austria
Gut dysfunction and non-alcoholic fatty liver

9:10 – 9:50  Louise Olofsson, Salghrenska Academy, University of Göteborg, Sweden
Mechanistic studies of the impact of the gut microbiome on obesity and type 2 diabetes. 

9:50 – 10:30  Remy Burcelin, INSERM, Paul Sabatier University, Toulouse, France.
Gut barrier and bacterial translocation in metabolic diseases.

10:30 – 11:00  Coffee break

11:00 – 11:40  Joël Doré, Metagenopolis, INRA, Paris, France
Do metagenomics approaches in cohorts support a key role for gut microbiome in metabolic diseases?

11:40 – 12:20  Two short talks selected from abstracts

12:30 – 14:00   Lunch

14:00 - 14:40  Patrizia Brigidi, University of Bologna, Italy
The gut microbiota of centenarians: signatures of longevity in the gut microbiota profiles.

14:40 – 18:00  The gut microbiome and CNS dysfunction (Chair: Jean-Philippe Pin)

14:40 – 15:20  Tristan Bolmont, Stemedica International, Lausanne, Switzerland
Gut microbiota alterations in Alzheimer’s disease: from preclinics to clinical studies.

15:20 – 15:50  Coffee break

15:50 – 16:30  Sylvie Claeysen, INSERM U661, University of Montpellier, France
Microbiota influence on Alzheimer’s development

16:30 – 17:10  Helen Vuong, UCLA, Los Angeles, USA
Maternal microbiome and neurodevelopment.

17:10 – 17:40  John Cryan, University College Cork, Ireland
Gut-brain axis revisited: which role for the gut microbiota in mood and depression?

17:40 – 18:00 Short talk selected from abstracts.

18:00 – 19:00 Keynote lecture (Chair: Maria Sibilia)
Emrah Altindis, Joslin Diabetes Center, Boston, USA
Viral insulin like peptides activate insulin and IGF-I receptor signalling: a paradigm shift in host microbe interactions.

19:00 – 21:00 Wine tasting and gala dinner

21:00  Posters session

Saturday 13th October

9:00 – 11:40  Therapeutic perspectives (Chair: David Carling)

9:00 – 9:40   Filipe Cabreiro, UCL, London, UK
Effects of drug-nutrient-microbe interactions on host physiology and lifespan.

9:40 – 10:20  Nathalie Delzenne, UCL, Brussels, Belgium
Feeding the gut microbiota with prebiotic dietary fibers: therapeutic interest in metabolic disorders.

10:20 – 10:50  Coffee break

10:50 – 11:30   Max Nieuwdorp, Akademisch Medisch Centrum, University of Amsterdam, The Netherlands
Gut microbial transfer from healthy to diseased (T2D) individuals.

11:30 – 12:30   Keynote lecture (Chair: Jacques E. Dumont)
Hubert Vidal, CarMeN laboratory, INSERM U1060, University of  Lyon, France.
Development of new probiotics for the treatment of diabetes/insulin resistance.

12:30 Lunch

13:30 Bus transfer

Subscribe to our email alerts